Scale helps healthcare, life sciences and health technology companies navigate, validate and grow within India through structured tracks, clinical networks, and operator-led support.
Upcoming cohort theme
The upcoming Scale cohort is focused on international medtech and medical device companies looking to enter or expand within the Indian market.
If you're building hardware-software platforms in diagnostics, surgical assistance, monitoring, rehabilitation, or point-of-care.
If India is on your roadmap, this cohort is designed for you.
Scale is designed for companies that are rethinking how healthcare is delivered, accessed and experienced. Here's what that looks like on ground.
01
Access to 500+ Hospitals Networks
Access 500+ hospitals, CROs, and care providers to validate, pilot, and unlock real commercial pathways for your innovation
02
Learn from Domain Experts & Leaders
Work with clinicians, operators, and investors who've built within the system and understand what drives real healthcare adoption
03
Support That Adapts to Your Stage
From validation to market entry, get tailored support across strategy, regulatory pathways, and go-to-market for India
04
A Long-Term Growth Platform
Access global markets and ongoing strategic support, staying within an ecosystem designed to help healthcare companies scale beyond India
Scale operates through two structured tracks; designed to meet founders where they are, whether you're exploring India for the first time or ready to bring a new model of care to market.
Track 1
India Market Discovery, Exploration & Validation
Track 2
Structured India Market Entry & Activation
Bionic prosthetics and rehabilitation robotics enabling functional recovery & mobility
VR-based rehabilitation and pain management platform for clinical and at-home use
Ambulance aggregation and emergency medical response coordination platform
Cardiac monitoring patch enabling continuous remote diagnostics and early detection
AI-driven chronic disease management and patient engagement platform
Wearable-driven health analytics and wellness monitoring
Digital health infrastructure for care coordination and patient management
AI-powered clinical decision support and healthcare automation platform
If India's healthcare market is on your horizon, and you're building with intent — this is your next move.
Healthcare, medtech, or life sciences companies with a working product or strong prototype
Global companies exploring or committed to India market entry
Indian startups looking for hospital access, regulatory navigation and commercial traction
Founders rethinking how care is accessed, delivered, or experienced; not just optimising what exists
What is Global HealthX Scale?
Scale is the market entry and growth vertical of Global HealthX. It works with Indian and global healthcare, life sciences, and health technology companies to navigate, validate and scale within the Indian market. Scale operates through two structured tracks- a discovery phase for market validation and a full activation programme for companies ready to launch. It is not a traditional accelerator. It is an operator-led programme backed by hospital networks, clinical advisory and regulatory experience- built for companies reimagining how care reaches people.
Is Scale a traditional accelerator?
No. Scale is structured differently from a typical accelerator. It is built on operator depth, institutional access and a long-term platform-building mandate. Companies don’t just attend sessions, they get direct access to 500+ hospitals, clinical networks, regulatory navigation, and commercial infrastructure. The programme is designed to compress the time it takes to enter and gain traction in India’s healthcare market, specifically for companies bringing new thinking to how care is delivered.
Who can apply to Scale?
Scale accepts applications from healthcare, life sciences and health technology companies- both Indian and global. If you’re an Indian startup building for the domestic market, or a global company with a credible India market entry thesis, you’re eligible. What matters most is a working product or strong prototype, a clear problem you’re solving, and genuine intent to operate in India.
What is the difference between Track 1 and Track 2?
Track 1 is a ~4-week discovery and validation phase designed for companies exploring India as a market. You walk away with an evidence-based Go / Refine / No-Go recommendation. Track 2 is a ~12-to-14-week activation programme for companies ready to enter India with hands-on support across hospital partnerships, regulatory pathways, pilot deployments and go-to-market execution.
What does the upcoming cohort focus on?
The current cohort is focused on international medtech and medical device companies entering the Indian market. This includes companies building hardware-software platforms in diagnostics, surgical assistance, monitoring, rehabilitation and point-of-care. Future cohorts may focus on different themes across healthcare and life sciences.
What does Scale offer beyond the programme?
Graduates of Scale become part of the Global HealthX ecosystem. This means continued access to hospital networks, mentors, investors and co-investment opportunities through Global HealthX Raise- our strategic capital vertical. Selected companies may also receive investment and long-term strategic support to continue scaling.
How do I apply to Scale?
Founders can apply directly through the application link on this page. Every submission is reviewed by the Scale team. We respond to companies that meet our threshold- strong product, clear problem relevance, and genuine intent to build within the Indian healthcare market.
Does Global HealthX invest in Scale companies?
Selected companies from the Scale programme may receive investment through Global HealthX Raise, our strategic capital vertical. Investment decisions are made based on the same criteria Raise applies across its portfolio- deep problem relevance, scalable platform, strong founding team and strategic ecosystem fit.
